Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is N/A as of Tuesday, October 6, 2026.
OPERATING MARGIN
N/A
Latigo Biotherapeutics Inc.
Market Cap
$978.09M
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$981.66M
Operating Margin
-130.20%
TTM Avg
-311.82%
3Y Avg
-583.08%
5Y Avg
-487.88%
Market Cap
$973.93M
Operating Margin
2.47%
TTM Avg
-2.95%
3Y Avg
4.03%
5Y Avg
7.25%
Market Cap
$982.46M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$992.14M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$996.65M
Operating Margin
-33.86%
TTM Avg
-38.38%
3Y Avg
-66.13%
5Y Avg
-173.51%
Market Cap
$998.69M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-59.79%
Market Cap
$953.81M
Operating Margin
-1149.52%
TTM Avg
-2324.93%
3Y Avg
-1162.47%
5Y Avg
-1162.47%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Latigo Biotherapeutics Inc. (LTGO) | $978.09M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $981.66M | -130.20% | -311.82% | -583.08% | -487.88% |
| Pacira BioSciences, Inc. (PCRX)vs › | $973.93M | 2.47% | -2.95% | 4.03% | 7.25% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $982.46M | 0.00% | 0.00% | 0.00% | 0.00% |
| Vor Biopharma Inc. (VOR)vs › | $992.14M | 0.00% | 0.00% | 0.00% | 0.00% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $996.65M | -33.86% | -38.38% | -66.13% | -173.51% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | 0.00% | 0.00% | 0.00% | -59.79% |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | -1149.52% | -2324.93% | -1162.47% | -1162.47% |
| Savara Inc. (SVRA)vs › | $952.91M | 0.00% | 0.00% | 0.00% | -3197.15% |
| Immatics N.V. (IMTX)vs › | $1.01B | -377.11% | -200.94% | -143.24% | -174.04% |
Gross Margin
N/A
Operating Margin
N/A
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
